U.S. Department of Health and Human Services — National Institutes of Health

Crystal structure of HIV-1 reverse transcriptase (RT) with DNA and the nonnucleoside inhibitor nevirapine

Autogenerated by

for

James Tyrwhitt Drake

Created on Wed, 2017-04-12 10:47, last updated on Wed, 2017-04-12 10:47

I Printed This

Remix It

Vertical Tabs

General Information

This Model was autogenerated from the "Quick Submit" tool.

Model ID

3DPX-004873

Category

Proteins, Macromolecules and Viruses

Keyword(s)

P51/P66, HETERO DIMER, NNRTI, NONNUCLEOSIDE INHIBITOR, AIDS, DNA, RECOMBINATION, RNA-directed DNA polymerase, viramune, DNA polymerase

Protein Data Bank ID

Experimental Method

X-RAY DIFFRACTION

Resolution

2.850

Model Details

Associated Species

Escherichia coli

Oligomeric Details

tetrameric

R-Factor

0.2520

Scattering Type

x-ray

Attribution

PubMed ID

Digital Object Identifier (DOI)

10.1038/nsmb.2223

Citation Title

HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.

Citation Year

2012

STL/VRML Files

PDB-3V81-ribbon-secondary.wrl

PDB-3V81-ribbon-rainbow.wrl

PDB-3V81-ribbon-bychain.wrl

PDB-3V81-ribbon.stl

PDB-3V81-surf-bychain.wrl

PDB-3V81-surf-hydropathy.wrl

PDB-3V81-surf-coulombic.wrl

PDB-3V81-surf.stl

X3D Files

PDB-3V81-ribbon-secondary.x3d

PDB-3V81-ribbon-rainbow.x3d

PDB-3V81-ribbon-bychain.x3d

PDB-3V81-ribbon.x3d

PDB-3V81-surf-bychain.x3d

PDB-3V81-surf-hydropathy.x3d

PDB-3V81-surf-coulombic.x3d

PDB-3V81-surf.x3d

Blender Files

PDB-3V81-ribbon-secondary.blend

PDB-3V81-ribbon-rainbow.blend

PDB-3V81-ribbon-bychain.blend

PDB-3V81-ribbon.blend

PDB-3V81-surf-bychain.blend

PDB-3V81-surf-hydropathy.blend

PDB-3V81-surf-coulombic.blend

PDB-3V81-surf.blend

PDB-3V81-ribbon-secondary.x3d

PDB-3V81-ribbon-rainbow.x3d

PDB-3V81-ribbon-bychain.x3d

PDB-3V81-ribbon.x3d

PDB-3V81-surf-bychain.x3d

PDB-3V81-surf-hydropathy.x3d

PDB-3V81-surf-coulombic.x3d

PDB-3V81-surf.x3d

QR Code for https://3dprint.nih.gov/discover/3dpx-004873

Rating

Licensing

Comments

0